These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

633 related items for PubMed ID: 18406994

  • 1. Antiplatelet agents and arterial thrombosis.
    Billett HH.
    Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
    [Abstract] [Full Text] [Related]

  • 2. Antiplatelet agents and arterial thrombosis.
    Billett HH.
    Clin Geriatr Med; 2006 Feb; 22(1):57-74, viii. PubMed ID: 16377467
    [Abstract] [Full Text] [Related]

  • 3. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ, Spinler SA.
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [Abstract] [Full Text] [Related]

  • 4. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
    Sauer H, Leschke M.
    Dtsch Med Wochenschr; 2006 Feb 24; 131(8):400-2. PubMed ID: 16479474
    [No Abstract] [Full Text] [Related]

  • 5. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire Int; 2009 Dec 24; 18(104):272-3. PubMed ID: 20027714
    [No Abstract] [Full Text] [Related]

  • 6. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H, Cohen M, Ezekowitz MD.
    J Invasive Cardiol; 2004 May 24; 16(5):271-8. PubMed ID: 15152137
    [Abstract] [Full Text] [Related]

  • 7. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
    Buresly K, Eisenberg MJ, Zhang X, Pilote L.
    Arch Intern Med; 2005 Apr 11; 165(7):784-9. PubMed ID: 15824298
    [Abstract] [Full Text] [Related]

  • 8. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A, Halperin JL.
    Thromb Haemost; 2008 Nov 11; 100(5):752-3. PubMed ID: 18989515
    [No Abstract] [Full Text] [Related]

  • 9. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V, Marín F.
    Thromb Haemost; 2008 Nov 11; 100(5):754-5. PubMed ID: 18989516
    [No Abstract] [Full Text] [Related]

  • 10. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
    Mohler ER.
    Catheter Cardiovasc Interv; 2009 Jul 01; 74 Suppl 1():S1-6. PubMed ID: 19213065
    [Abstract] [Full Text] [Related]

  • 11. Combined antithrombotic therapy for acute coronary syndrome.
    Gawaz M, Müller I, Besta F.
    Semin Vasc Med; 2003 May 01; 3(2):163-76. PubMed ID: 15199479
    [Abstract] [Full Text] [Related]

  • 12. [Platelet aggregation inhibitors in diabetes mellitus].
    Abrahamian H.
    Acta Med Austriaca; 1999 May 01; 26(5):137-41. PubMed ID: 11512189
    [Abstract] [Full Text] [Related]

  • 13. [Clopidogrel as basic therapy in high-risk stroke patients].
    Mattle HP.
    Praxis (Bern 1994); 2004 Aug 18; 93(34):1364. PubMed ID: 15468694
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
    Wang TH, Bhatt DL, Fox KA, Steinhubl SR, Brennan DM, Hacke W, Mak KH, Pearson TA, Boden WE, Steg PG, Flather MD, Montalescot G, Topol EJ, CHARISMA Investigators.
    Eur Heart J; 2007 Sep 18; 28(18):2200-7. PubMed ID: 17673448
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
    Konstantopoulos K, Mousa SA.
    Curr Opin Investig Drugs; 2001 Aug 18; 2(8):1086-92. PubMed ID: 11892918
    [Abstract] [Full Text] [Related]

  • 18. Combination antiplatelet agents in ischemic cerebrovascular disease.
    Moussouttas M, Papamitsakis N.
    Mt Sinai J Med; 2005 Jan 18; 72(1):16-22. PubMed ID: 15682258
    [Abstract] [Full Text] [Related]

  • 19. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J.
    J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153
    [Abstract] [Full Text] [Related]

  • 20. Antiplatelet therapy in acute coronary syndromes.
    Aragam KG, Bhatt DL.
    J Cardiovasc Pharmacol Ther; 2011 Mar 15; 16(1):24-42. PubMed ID: 20924098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.